Nu Skin Enterprises, Inc.

NUS Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.87 0.13 +2.74%
Market cap
$237.1M
P/E
0.0×
Fwd P/E
5.9×
Dividend yield
4.93%
F-score
7/9
Altman Z
3.78
Beneish M
−2.35
Dividend safety
70/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
1,485.16 1,732.08 1,969.13 2,225.66 2,695.67 2,581.93 2,420.42 2,679.01 2,279.10 2,207.80
Revenue Growth
(14.26%) (12.04%) (11.53%) (17.44%) 4.41% 6.67% (9.65%) 17.55% 3.23% (1.75%)
Cost of Revenue
453.76 550.23 611.85 630.92 675.22 658.03 581.42 634.14 502.08 500.46
Gross Profit
1,031.40 1,181.85 1,357.28 1,594.74 2,020.45 1,923.91 1,839.00 2,044.87 1,777.02 1,707.34
SG&A Expenses
940.52 1,131.08 1,289.22 1,435.40 1,734.58 1,666.34 1,571.57 1,733.32 1,502.54 1,476.24
Operating Income
65.76 (151.58) 48.27 110.85 233.99 257.56 267.43 240.86 274.48 231.10
Non-operating Income/Expense
130.43 (23.47) (21.69) (21.88) (1.53) (1.33) (12.25) (21.19) (8.92) (18.26)
Non-operating Interest Expenses
13.95 26.41 25.56 13.49 — — — — — —
EBT
196.20 (175.05) 26.58 88.97 232.46 256.23 255.17 219.67 265.57 212.84
Income Tax Provision
35.99 (28.46) 17.98 (15.81) 85.19 64.88 81.62 97.78 136.13 69.75
Income after Tax
160.20 (146.59) 8.60 104.78 147.27 191.36 173.55 121.89 129.44 143.09
Dividends (Preferred)
0.00 — 0.00 — 0.00 — — — 0.00 —
Net Income Common
160.20 (146.59) 8.60 104.78 147.27 191.36 173.55 121.89 129.44 143.09
EPS (Basic)
3.25 (2.95) 0.17 2.10 2.93 3.66 3.13 2.21 2.45 2.58
EPS (Diluted)
3.18 (2.95) 0.17 2.07 2.86 3.63 3.10 2.16 2.36 2.55
Shares (Basic, Weighted)
49.29 49.66 49.71 50.00 50.19 52.30 55.52 55.17 52.81 55.41
Shares (Diluted, Weighted)
50.30 49.66 49.86 50.53 51.43 52.77 55.93 56.48 54.85 56.10
Gross Margin
69.45% 68.23% 68.93% 71.65% 74.95% 74.51% 75.98% 76.33% 77.97% 77.33%
EBIT Margin
4.43% (8.75%) 2.45% 4.98% 8.68% 9.98% 11.05% 8.99% 12.04% 10.47%
EBT margin
13.21% (10.11%) 1.35% 4.00% 8.62% 9.92% 10.54% 8.20% 11.65% 9.64%
Net Profit Margin
10.79% (8.46%) 0.44% 4.71% 5.46% 7.41% 7.17% 4.55% 5.68% 6.48%
Free Cash Flow Margin
3.10% 4.05% 3.05% 2.20% 2.71% 12.21% 4.62% 4.94% 10.64% 10.19%
EBITDA
118.02 (81.77) 119.19 183.35 310.31 331.56 344.08 323.86 346.05 303.50
EBIT
65.76 (151.58) 48.27 110.85 233.99 257.56 267.43 240.86 274.48 231.10
Income from Continuous Operations
160.20 (146.59) 8.60 104.78 147.27 191.36 173.55 121.89 129.44 143.09
Consolidated Net Income/Loss
160.20 (146.59) 8.60 104.78 147.27 191.36 173.55 121.89 129.44 143.09
EPS (Basic, from Continuous Ops)
3.25 (2.95) 0.17 2.10 2.93 3.66 3.13 2.21 2.45 2.58
EPS (Basic, Consolidated)
3.25 (2.95) 0.17 2.10 2.93 3.66 3.13 2.21 2.45 2.58
EPS (Diluted, from Cont. Ops)
3.18 (2.95) 0.17 2.07 2.86 3.63 3.10 2.16 2.36 2.55
Shares (Diluted, Average)
50.30 49.66 49.86 50.53 51.43 52.77 55.93 56.48 54.85 56.10
EPS (Diluted, Consolidated)
3.18 (2.95) 0.17 2.07 2.86 3.63 3.10 2.16 2.36 2.55
EBITDA Margin
7.95% (4.72%) 6.05% 8.24% 11.51% 12.84% 14.22% 12.09% 15.18% 13.75%
Operating Cash Flow Margin
5.41% 6.45% 6.02% 4.86% 5.25% 14.68% 7.35% 7.57% 13.28% 12.47%

Fold the line items

In millions of $ except per-share values · columns are period end dates